Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Beyond aspirin—cancer prevention with statins, metformin and bisphosphonates
Naomi Gronich, Gad Rennert
Nature Reviews Clinical Oncology (2013) Vol. 10, Iss. 11, pp. 625-642
Closed Access | Times Cited: 158

Showing 1-25 of 158 citing articles:

The emerging roles of YAP and TAZ in cancer
Toshiro Moroishi, Carsten Gram Hansen, Kun‐Liang Guan
Nature reviews. Cancer (2015) Vol. 15, Iss. 2, pp. 73-79
Open Access | Times Cited: 1051
Biology, detection, and clinical implications of circulating tumor cells
Simon A. Joosse, Tobias M. Gorges, Klaus Pantel
EMBO Molecular Medicine (2014) Vol. 7, Iss. 1, pp. 1-11
Open Access | Times Cited: 500
Drug repurposing in oncology—patient and health systems opportunities
Francesco Bertolini, Vikas P. Sukhatme, Gauthier Bouche
Nature Reviews Clinical Oncology (2015) Vol. 12, Iss. 12, pp. 732-742
Closed Access | Times Cited: 275
Targeting Inflammation in Cancer Prevention and Therapy
Jelena Todoric, Laura Antonucci, Michael Karin
Cancer Prevention Research (2016) Vol. 9, Iss. 12, pp. 895-905
Open Access | Times Cited: 254
The Mevalonate Pathway Is a Druggable Target for Vaccine Adjuvant Discovery
Yun Xia, Yonghua Xie, Zhengsen Yu, et al.
Cell (2018) Vol. 175, Iss. 4, pp. 1059-1073.e21
Open Access | Times Cited: 198
The Role of Hippo Pathway in Cancer Stem Cell Biology.
Jae Hyung Park, Ji Eun Shin, Hyun Woo Park
PubMed (2018) Vol. 41, Iss. 2, pp. 83-92
Closed Access | Times Cited: 192
Causal Inference in Cancer Epidemiology: What Is the Role of Mendelian Randomization?
James Yarmolinsky, Kaitlin H. Wade, Rebecca C. Richmond, et al.
Cancer Epidemiology Biomarkers & Prevention (2018) Vol. 27, Iss. 9, pp. 995-1010
Open Access | Times Cited: 154
Flaxseed Lignans as Important Dietary Polyphenols for Cancer Prevention and Treatment: Chemistry, Pharmacokinetics, and Molecular Targets
Franklyn De Silva, Jane Alcorn
Pharmaceuticals (2019) Vol. 12, Iss. 2, pp. 68-68
Open Access | Times Cited: 135
Cholesterol and beyond - The role of the mevalonate pathway in cancer biology
Andy Göbel, Martina Rauner, Lorenz C. Hofbauer, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1873, Iss. 2, pp. 188351-188351
Closed Access | Times Cited: 128
Metformin directly binds the alarmin HMGB1 and inhibits its proinflammatory activity
Takahiro Horiuchi, Natsumi Sakata, Yoshihiro Narumi, et al.
Journal of Biological Chemistry (2017) Vol. 292, Iss. 20, pp. 8436-8446
Open Access | Times Cited: 99
Inhibition of the mevalonate pathway affects epigenetic regulation in cancer cells
Heidrun Karlic, Roman Thaler, Christopher Gerner, et al.
Cancer Genetics (2015) Vol. 208, Iss. 5, pp. 241-252
Open Access | Times Cited: 95
Metformin and Prostate Cancer: a New Role for an Old Drug
Jessica Whitburn, Claire M. Edwards, Prasanna Sooriakumaran
Current Urology Reports (2017) Vol. 18, Iss. 6
Open Access | Times Cited: 94
High-intensity statins are associated with improved clinical activity of PD-1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients
Luca Cantini, Federica Pecci, Daan P. Hurkmans, et al.
European Journal of Cancer (2020) Vol. 144, pp. 41-48
Closed Access | Times Cited: 87
The Hippo Pathway in Prostate Cancer
Omar Salem, Carsten Gram Hansen
Cells (2019) Vol. 8, Iss. 4, pp. 370-370
Open Access | Times Cited: 86
The anticancer potential of metformin on prostate cancer
Saher Zaidi, Jason Gandhi, Gunjan Joshi, et al.
Prostate Cancer and Prostatic Diseases (2019) Vol. 22, Iss. 3, pp. 351-361
Closed Access | Times Cited: 83
Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome‐driven neoplasms
Tsuyoshi Hamada, Jonathan A. Nowak, Danny A. Milner, et al.
The Journal of Pathology (2019) Vol. 247, Iss. 5, pp. 615-628
Open Access | Times Cited: 81
Stem cells from adipose tissue and breast cancer: hype, risks and hope
Francesco Bertolini, J-Y Petit, Mikhail G. Kolonin
British Journal of Cancer (2015) Vol. 112, Iss. 3, pp. 419-423
Open Access | Times Cited: 86
Role of YAP/TAZ transcriptional regulators in resistance to anti-cancer therapies
Min Hwan Kim, Joon Kim
Cellular and Molecular Life Sciences (2016) Vol. 74, Iss. 8, pp. 1457-1474
Closed Access | Times Cited: 85
From rapalogs to anti-aging formula
Mikhail V. Blagosklonny
Oncotarget (2017) Vol. 8, Iss. 22, pp. 35492-35507
Open Access | Times Cited: 82
Statins: a role in breast cancer therapy?
Signe Borgquist, O. Bjarnadottir, Siker Kimbung, et al.
Journal of Internal Medicine (2018) Vol. 284, Iss. 4, pp. 346-357
Open Access | Times Cited: 78
Statin Use and Risk of Pancreatic Cancer
Yun Zhang, Mingming Liang, Chenyu Sun, et al.
Pancreas (2019) Vol. 48, Iss. 2, pp. 142-150
Closed Access | Times Cited: 74
Systematic review with network meta-analysis: statins and risk of hepatocellular carcinoma
Yaoyao Zhou, Gui‐Qi Zhu, Yue Wang, et al.
Oncotarget (2016) Vol. 7, Iss. 16, pp. 21753-21762
Open Access | Times Cited: 73
Statin use and risk of liver cancer: an update meta-analysis
Meng Shi, Huiling Zheng, Biao Nie, et al.
BMJ Open (2014) Vol. 4, Iss. 9, pp. e005399-e005399
Open Access | Times Cited: 69
The Association of Statin Use after Cancer Diagnosis with Survival in Pancreatic Cancer Patients: A SEER-Medicare Analysis
Christie Y. Jeon, Stephen J. Pandol, Bechien U. Wu, et al.
PLoS ONE (2015) Vol. 10, Iss. 4, pp. e0121783-e0121783
Open Access | Times Cited: 67
Effect of Metformin and Statin Use on Survival in Pancreatic Cancer Patients: a Systematic Literature Review and Meta-analysis
E Jian‐Yu, Judith M. Graber, Shou‐En Lu, et al.
Current Medicinal Chemistry (2017) Vol. 25, Iss. 22, pp. 2595-2607
Open Access | Times Cited: 66
Page 1 - Next Page

Scroll to top